Characteristics shifting of heart disease in pregnancy: A report from low middle-income country

  • Cyntia Puspa Pitaloka
    Master Program of Public Health, Faculty of Public Health, Universitas Airlangga, Surabaya, Indonesia. https://orcid.org/0000-0002-0280-5772
  • Absa Secka
    Master Program of Public Health, Faculty of Public Health, Universitas Airlangga, Surabaya, Indonesia.
  • Ernawati Ernawati
    Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Airlangga, Surabaya / Dr. Soetomo General Hospital; Department of Obstetrics & Gynaecology, Airlangga University Academic Hospital, Surabaya, Indonesia.
  • Agus Sulistyono
    Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Airlangga, Surabaya / Dr. Soetomo General Hospital, Indonesia.
  • Hermanto Tri Juwono
    Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Airlangga, Surabaya / Dr. Soetomo General Hospital, Indonesia.
  • Erry Gumilar Dachlan
    Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Airlangga, Surabaya / Dr. Soetomo General Hospital, Indonesia.
  • Aditiawarman Aditiawarman
    Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Airlangga, Surabaya / Dr. Soetomo General Hospital, Indonesia.

ABSTRACT

Background: Heart disease in pregnancy is one of the leading causes of maternal mortality and morbidity in developing countries. However, the characteristics of the disease vary between countries and regions. This study aimed to present the characteristics of pregnant women with heart disease in an economically advantageous region of a developing country.
Design and methods: A cross-sectional study was conducted using data from the Weekly Report of Obstetrics and Gynaecology Department to assess pregnant women with heart disease characteristics and pregnancy outcomes. A total sample of 69 pregnant women with heart disease regarding their gestational age was included in the study. Variables observed were maternal characteristics, heart disease's clinical parameters, and maternal and neonatal outcomes. Chi-square test was used to examine the different characteristics of congenital and acquired heart disease groups.
Results: The prevalence of cardiac disease in pregnancy was 5.19%. Fifty-three point six percent of pregnant women with heart disease were suffered from congenital heart disease (CHD), while 46.4% were acquired heart disease (AHD). Most labor methods were Cesarean delivery, and 69.6% of women experienced cardiac complications. Maternal death was reported in 8.69% of cases. Four cases were CHD complicated by pulmonary hypertension, which leads to Eisenmenger syndrome. Two other cases were AHD complicated by Peripartum Cardiomyopathies. Although statistically insignificant, complications are more common in the AHD group than CHD.
Conclusion: Cardiac disease prevalence in pregnancy is considered high, with CHD as the most common case, which significantly differs from other developing countries.

REFERENCES

Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147–97. DOI: https://doi.org/10.1093/eurheartj/ehr218

Elkayam U, Goland S, Pieper PG, Silversides CK. High-risk cardiac disease in pregnancy: part I. J Am Coll Cardiol 2016;68:396–410. DOI: https://doi.org/10.1016/j.jacc.2016.05.048

Chhetri S, Shrestha NR, Pilgrim T. Pregnancy complicated by heart disease in Nepal. Heart Asia 2014;6:26–9. DOI: https://doi.org/10.1136/heartasia-2013-010396

Özlem Bozkaya V, Kaplan ZAO, Özgü E, Engin-Üstün Y. Screening and evaluation of newly diagnosed cardiovascular diseases in first-trimester asymptomatic pregnant women in a tertiary antenatal care center in Turkey. Anatol J Cardiol 2020;23:99–104. DOI: https://doi.org/10.14744/AnatolJCardiol.2019.55267

Yang L, Yamamoto-Hanada K, Ishitsuka K, et al. Medical and surgical complications in pregnancy and obstetric labour complications in the Japan Environment and Children’s Study (JECS) cohort: a birth cohort study. J Obstet Gynaecol 2020;40:918–24. DOI: https://doi.org/10.1080/01443615.2019.1673709

Muninggar L, Yusuf M, Prasetyo B. Maternal mortality risk factor in pregnancy with heart disease at Dr. Soetomo General Hospital, Surabaya, Indonesia. Majalah Obstetri dan Ginekologi 2019;27:17–23. DOI: https://doi.org/10.20473/mog.V1I12019.17-23

Mocumbi A, Sliwa K, Soma-Pillay P. Medical disease as a cause of maternal mortality:the pre-imminence of cardiovascular pathology. Cardiovasc J Afr 2016;27:84–8. DOI: https://doi.org/10.5830/CVJA-2016-018

Nguyen Manh T, Bui Van N, Le Thi H, et al. Pregnancy with heart disease: Maternal outcomes and risk factors for fetal growth restriction. Int J Environ Res Public Health 2019;16:2075. DOI: https://doi.org/10.3390/ijerph16122075

Moller A-B, Petzold M, Chou D, Say L. Early antenatal care visit: a systematic analysis of regional and global levels and trends of coverage from 1990 to 2013. The Lancet Global Health 2017;5:e977–83. DOI: https://doi.org/10.1016/S2214-109X(17)30325-X

Laksono AD, Rukmini R, Wulandari RD. Regional disparities in antenatal care utilization in Indonesia. PLOS One 2020;15:e0224006. DOI: https://doi.org/10.1371/journal.pone.0224006

World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience. 2016. Available from: https://apps.who.int/iris/bitstream/handle/10665/250796/9789241549912-eng.pdf?sequence=1

Benova L, Tunçalp Ö, Moran AC, Campbell OMR. Not just a number: examining coverage and content of antenatal care in low-income and middle-income countries. BMJ Global Health 2018;3:e000779. DOI: https://doi.org/10.1136/bmjgh-2018-000779

French Katharine A., Poppas Athena. Rheumatic heart disease in pregnancy. Circulation 2018;137:817–9. DOI: https://doi.org/10.1161/CIRCULATIONAHA.118.033465

Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018;39:3165–241. DOI: https://doi.org/10.1093/eurheartj/ehy478

Cauldwell M, Gatzoulis M, Steer P. Congenital heart disease and pregnancy: A contemporary approach to counselling, pre-pregnancy investigations and the impact of pregnancy on heart function. Obstet Med 2017;10:53–7. DOI: https://doi.org/10.1177/1753495X16687905

Sullivan EA, Vaughan G, Li Z, et al. The high prevalence and impact of rheumatic heart disease in pregnancy in First Nations populations in a high-income setting: a prospective cohort study. BJOG 2020;127:47–56. DOI: https://doi.org/10.1111/1471-0528.15938

Rochmatin H. [Determinants of Maternal Mortality in the City of Surabaya in 2015-2017].[Article in Indonesian]. JBK 2019;7:178. DOI: https://doi.org/10.20473/jbk.v7i2.2018.178-187

Soedarmono YSM. The Indonesian approach to reduce maternal mortality. ISBT Sci Ser 2017;12:272–80. DOI: https://doi.org/10.1111/voxs.12317

Warsita IGN, Negara KS, Wiradnyana AAGP, Aryana MBD. [Characteristics of pregnant patients with heart disease at Sanglah General Hospital Denpasar].[Article in Indonesian]. Medicina 2019;50. DOI: https://doi.org/10.15562/medicina.v50i3.715

Iftikhar SF, Biswas M. Cardiac disease in pregnancy. StatPearls [Internet]: Treasure Island; 2020.

Diana S, Wahyuni CU, Prasetyo B. Maternal complications and risk factors for mortality. J Public Health Res 2020;9:1842. DOI: https://doi.org/10.4081/jphr.2020.1842

Ministry of Health Republic of Indonesia. Indonesia Health Profile 2018. Accessed: 2020 Jul 24. Jakarta: Ministry of Health Republic of Indonesia; 2019. Available from: https://pusdatin.kemkes.go.id/resources/download/pusdatin/profil-kesehatan-indonesia/PROFIL_KESEHATAN_2018_1.pdf

Nqayana T, Moodley J, Naidoo D. Cardiac disease in pregnancy. Cardiovasc J Afr 2008;19:145–51.

Kurniawaty J, Widyastuti Y. Outcome of adult congenital heart disease patients undergoing cardiac surgery: clinical experience of dr. Sardjito hospital. BMC Proceedings 2019;13:16. DOI: https://doi.org/10.1186/s12919-019-0178-5

Pedersen LM, Pedersen TAL, Ravn HB, Hjortdal VE. Outcomes of pregnancy in women with tetralogy of Fallot. Cardiol Young 2008;18:423–9. DOI: https://doi.org/10.1017/S1047951108002345

Greutmann M, Pieper PG. Pregnancy in women with congenital heart disease. Eur Heart J 2015;36:2491–9. DOI: https://doi.org/10.1093/eurheartj/ehv288

Bredy C, Mongeon F-P, Leduc L, et al. Pregnancy in adults with repaired/unrepaired atrial septal defect. J Thorac Dis 2018;10:S2945–52. DOI: https://doi.org/10.21037/jtd.2017.10.130

Petrus AHJ, Jongert BL, Kiès P, et al. Evaluation of mode of birth in pregnant women with heart disease. Eur J Obstet Gynecol Reprod Biol 2020;248:150–5. DOI: https://doi.org/10.1016/j.ejogrb.2020.03.013

Ashrafi R, Curtis SL. Heart disease and pregnancy. Cardiol Ther 2017;6:157–73. DOI: https://doi.org/10.1007/s40119-017-0096-4

Owens A, Yang J, Nie L, et al. Neonatal and maternal outcomes in pregnant women with cardiac disease. J Am Heart Assoc 2018;7:e009395. DOI: https://doi.org/10.1161/JAHA.118.009395

Silversides CK, Grewal J, Mason J, et al. Pregnancy outcomes in women with heart disease: The CARPREG II Study. J Am Coll Cardiol 2018;71:2419–30. DOI: https://doi.org/10.1016/j.jacc.2018.02.076

Sliwa K, Baris L, Sinning C, et al. Pregnant women with uncorrected congenital heart disease. JACC: Heart Fail 2020;8:100–10. DOI: https://doi.org/10.1016/j.jchf.2019.09.001

Goya M, Casellas M, Merced C, et al. Predictors of obstetric complications in women with heart disease. J Matern Fetal Neonatal Med 2016;29:2306-11.

Makino Y, Matsuda Y, Mitani M, et al. Risk factors associated with preterm delivery in women with cardiac disease. J Cardiol 2012;59:291–8. DOI: https://doi.org/10.1016/j.jjcc.2011.11.006